{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:51:41Z","timestamp":1790815901495,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior\u2014CAPES and Funda\u00e7\u00e3o de Amparo a Pesquisa do Estado de Minas Gerais\u2014FAPEMIG","award":["PPM-00117-14"],"award-info":[{"award-number":["PPM-00117-14"]}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["305154\/2014-1"],"award-info":[{"award-number":["305154\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ijantimicag.2017.04.005","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T17:47:28Z","timestamp":1493056048000},"page":"695-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Atorvastatin as a promising anticryptococcal agent"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-6910","authenticated-orcid":false,"given":"Noelly de Queiroz","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marliete Carvalho","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Furtado Ferreira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hellem Cristina Silva","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena V\u00edvien","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alide Caroline Lima","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julliana Ribeiro Alves","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Freitas","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauber Ribeiro de Sousa","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Frases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Alves","family":"Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Aparecida","family":"de Resende Stoianoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Assis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2013\/675213","article-title":"Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0015","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1128\/CMR.00126-13","article-title":"Cryptococcus gattii infections","volume":"27","author":"Chen","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl.","key":"10.1016\/j.ijantimicag.2017.04.005_bib0020","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.amjmed.2011.10.010","article-title":"The impact of the host on fungal infections","volume":"125","author":"Perfect","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0025","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis","volume":"12","author":"Butts","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkt449","article-title":"Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms","volume":"69","author":"Delattin","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.300.1.195","article-title":"Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone","volume":"300","author":"Courchesne","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0040","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1128\/AAC.02810-15","article-title":"The repurposing of aspirin and ibuprofen as candidate anti-cryptococcus drugs","volume":"60","author":"Ogundeji","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0045","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/AAC.00212-12","article-title":"The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections","volume":"56","author":"Zhai","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0050","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00253-002-0932-9","article-title":"Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs","volume":"58","author":"Manzoni","year":"2002","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2875-11-13","article-title":"Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model","volume":"11","author":"Souraud","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0065","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nm.3911","article-title":"Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections","volume":"21","author":"Dalli","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0070","doi-asserted-by":"crossref","first-page":"e742","DOI":"10.3399\/bjgp11X606654","article-title":"Risk of pneumonia in patients taking statins: population-based nested case\u2013control study","volume":"61","author":"Vinogradova","year":"2011","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0075","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.168.19.2081","article-title":"Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29,900 patients","volume":"168","author":"Thomsen","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0080","first-page":"2294","article-title":"Beneficial effects of statins on outcomes in pneumonia: a systematic review and meta-analysis","volume":"18","author":"Cheng","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.18433\/J34307","article-title":"Statins reduce mortality after non-severe but not after severe pneumonia: a systematic review and meta-analysis","volume":"18","author":"Jia","year":"2015","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.riam.2012.09.006","article-title":"Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification","volume":"30","author":"Cabral","year":"2013","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0095","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bjid.2015.06.001","article-title":"Simvastatin inhibits planktonic cells and biofilms of Candida and Cryptococcus species","volume":"19","author":"Brilhante","year":"2015","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6968.2006.00370.x","article-title":"Growth inhibition of Candida species and Aspergillus fumigatus by statins","volume":"262","author":"Macreadie","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.2010.01972.x","article-title":"In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi","volume":"307","author":"Nyilasi","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0110","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0115","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/AAC.06098-11","article-title":"Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii","volume":"56","author":"Santos","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112669","article-title":"Fluconazole alters the polysaccharide capsule of Cryptococcus gattii and leads to distinct behaviors in murine Cryptococcosis","volume":"9","author":"Santos","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0125","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1128\/EC.00122-07","article-title":"Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cations","volume":"6","author":"Nimrichter","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3181\/00379727-78-19135","article-title":"A new method for studying mechanics of breathing using cathode ray oscillograph","volume":"78","author":"Dubois","year":"1951","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0135","series-title":"Bone marrow-derived macrophages (BMM): isolation and applications","author":"Weischenfeldt","year":"2008"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/mmy\/myt011","article-title":"IFN-\u03b3 impairs Trichophyton rubrum proliferation in a murine model of dermatophytosis through the production of IL-1\u03b2 and reactive oxygen species","volume":"52","author":"Baltazar","year":"2014","journal-title":"Med Mycol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","author":"Ostrosky-Zeichner","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0150","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1002\/anie.201404761","article-title":"Advancing the drug discovery and development process","volume":"53","author":"Nicolaou","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2013.10.013","article-title":"Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPAR\u03b3 receptors","volume":"720","author":"Malekinejad","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0160","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/AAC.34.9.1660","article-title":"Effects of lovastatin (mevinolin) on sterol levels and on activity of azoles in Saccharomyces cerevisiae","volume":"34","author":"Lorenz","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0165","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.qco.0000235166.16421.e5","article-title":"The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine","volume":"19","author":"Chamilos","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0170","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14787210.2014.856755","article-title":"Is there a role for statins in fungal infections?","volume":"11","author":"Bergman","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.riam.2013.10.004","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model","volume":"31","author":"Andrade-Pav\u00f3n","year":"2014","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-2164(09)01204-0","article-title":"The capsule of the fungal pathogen Cryptococcus neoformans","volume":"68","author":"Zaragoza","year":"2009","journal-title":"Adv Appl Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0185","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/IAI.00111-10","article-title":"Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter","volume":"78","author":"Fonseca","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029561","article-title":"Capsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cells","volume":"7","author":"Araujo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrmicro2522","article-title":"Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box","volume":"9","author":"Kronstad","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0200","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.bpj.2009.04.043","article-title":"The elastic properties of the Cryptococcus neoformans capsule","volume":"97","author":"Frases","year":"2009","journal-title":"Biophys J"},{"key":"10.1016\/j.ijantimicag.2017.04.005_bib0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micinf.2015.08.017","article-title":"Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265","volume":"18","author":"Sorrell","year":"2016","journal-title":"Microbes Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T15:53:22Z","timestamp":1656863602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0924857917301322"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin as a promising anticryptococcal agent","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}